Incannex Healthcare Limited (IXHL)
USD 0.5
(-3.86%)
USD 0.5
(-3.86%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | -10.01 Million USD | 0.0% |
| 2023 | -416.16 Thousand AUD | -23.3% |
| 2022 | -337.51 Thousand AUD | -89.55% |
| 2021 | -178.06 Thousand AUD | -241.49% |
| 2020 | 125.85 Thousand AUD | -17.64% |
| 2019 | 152.8 Thousand AUD | -31.5% |
| 2018 | 223.07 Thousand AUD | -1.75% |
| 2017 | 227.04 Thousand AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | -100.0% |
| 2014 | 40.16 Thousand AUD | 192.43% |
| 2013 | 13.73 Thousand AUD | -18.62% |
| 2012 | 16.87 Thousand AUD | -29.82% |
| 2011 | 24.04 Thousand AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | -5.59 Million USD | 0.0% |
| 2024 Q3 | -6.59 Million USD | -17.94% |
| 2024 Q4 | - USD | 0.0% |
| 2023 Q4 | -416.16 Thousand AUD | 0.0% |
| 2023 FY | -416.16 Thousand AUD | -23.3% |
| 2023 Q2 | -707.48 Thousand AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 FY | - AUD | -89.55% |
| 2022 Q4 | - AUD | 0.0% |
| 2021 Q2 | 212.92 Thousand AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 FY | - AUD | -241.49% |
| 2020 Q2 | 187.43 Thousand AUD | 0.0% |
| 2020 FY | 125.85 Thousand AUD | -17.64% |
| 2020 Q4 | 183.15 Thousand AUD | 0.0% |
| 2019 FY | 152.8 Thousand AUD | -31.5% |
| 2019 Q4 | 152.8 Thousand AUD | 0.0% |
| 2019 Q2 | 155.72 Thousand AUD | 0.0% |
| 2018 FY | 223.07 Thousand AUD | -1.75% |
| 2018 Q2 | 224.24 Thousand AUD | 0.0% |
| 2018 Q4 | 223.07 Thousand AUD | 0.0% |
| 2017 FY | 227.04 Thousand AUD | 0.0% |
| 2017 Q4 | 227.04 Thousand AUD | 0.0% |
| 2017 Q2 | 121.88 Thousand AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q1 | - AUD | 0.0% |
| 2015 Q1 | 10.04 Thousand AUD | -75.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q2 | 3469.00 AUD | -65.45% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 FY | - AUD | -100.0% |
| 2014 FY | 40.16 Thousand AUD | 192.43% |
| 2014 Q1 | 3433.50 AUD | -75.0% |
| 2014 Q2 | 44.6 Thousand AUD | 1199.08% |
| 2014 Q3 | 10.04 Thousand AUD | -77.49% |
| 2014 Q4 | 40.16 Thousand AUD | 300.03% |
| 2013 FY | 13.73 Thousand AUD | -18.62% |
| 2013 Q4 | 13.73 Thousand AUD | 300.0% |
| 2013 Q3 | 3433.50 AUD | -41.83% |
| 2013 Q2 | 5903.00 AUD | 39.91% |
| 2013 Q1 | 4219.00 AUD | -75.0% |
| 2012 Q2 | 56.5 Thousand AUD | 839.89% |
| 2012 FY | 16.87 Thousand AUD | -29.82% |
| 2012 Q4 | 16.87 Thousand AUD | 300.0% |
| 2012 Q3 | 4219.00 AUD | -92.53% |
| 2012 Q1 | 6012.00 AUD | -75.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2011 Q4 | 24.04 Thousand AUD | 300.0% |
| 2011 FY | 24.04 Thousand AUD | 0.0% |
| 2011 Q3 | 6012.00 AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 Q2 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q1 | - AUD | 0.0% |
| 2008 Q2 | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2008 Q3 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | 309.123% |
| Safety Shot Inc | 1.86 Million USD | 635.663% |
| Bright Green Corporation | - USD | Infinity% |
| Embecta Corp. | 152.1 Million USD | 106.584% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 109.007% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 247.954% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 130.976% |
| Dynavax Technologies Corporation | 53.29 Million USD | 118.793% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 115.261% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 185.988% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 109.597% |
| PainReform Ltd. | - USD | Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 274.637% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 274.637% |
| SCYNEXIS, Inc. | - USD | Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | 1336.791% |
| Journey Medical Corporation | 10.2 Million USD | 198.129% |
| Alpha Teknova, Inc. | 11.59 Million USD | 186.381% |
| Procaps Group, S.A. | 96.83 Million USD | 110.343% |
| Theratechnologies Inc. | 6.06 Million USD | 265.101% |
| Harrow Health, Inc. | 10.86 Million USD | 192.16% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 468.334% |
| Biofrontera Inc. | 10.9 Million USD | 191.813% |
| DURECT Corporation | 2.21 Million USD | 551.329% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 112.938% |
| Cronos Group Inc. | 30.33 Million USD | 133.01% |
| OptiNose, Inc. | 8.05 Million USD | 224.379% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | 1001500100.0% |
| Kala Pharmaceuticals, Inc. | - USD | Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 275.732% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 135.448% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | 474.097% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 317.275% |
| Radius Health, Inc. | 278.64 Million USD | 103.594% |
| Universe Pharmaceuticals INC | 3.34 Million USD | 399.557% |
| ProPhase Labs, Inc. | 3.84 Million USD | 360.739% |
| Phibro Animal Health Corporation | 265.91 Million USD | 103.766% |
| Procaps Group S.A. | 96.83 Million USD | 110.343% |
| Alvotech | 74.43 Million USD | 113.455% |
| TherapeuticsMD, Inc. | - USD | Infinity% |
| Viatris Inc. | 3.46 Billion USD | 100.289% |
| Rockwell Medical, Inc. | 5.87 Million USD | 270.584% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 179.276% |
| SIGA Technologies, Inc. | 64.21 Million USD | 115.595% |
| Tilray Brands, Inc. | 252.08 Million USD | 103.973% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 125.051% |
| Shineco, Inc. | 1.58 Million USD | 730.459% |
| PetIQ, Inc. | 159.3 Million USD | 106.287% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | -6455.263% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 126.149% |
| Alimera Sciences, Inc. | 1.87 Million USD | 632.996% |
| Silver Spike Investment Corp. | - USD | Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 126.575% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | 721.899% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 323.4% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 4037.457% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 196.484% |
| Hempacco Co., Inc. | 2.54 Million USD | 493.884% |
| Talphera, Inc. | - USD | Infinity% |
| Alvotech | 74.43 Million USD | 113.455% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 120.955% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 115.641% |
| Currenc Group, Inc. | 732.91 Thousand USD | 1466.469% |
| Kamada Ltd. | 87.74 Million USD | 111.414% |
| Indivior PLC | 141.79 Million USD | 107.063% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | 2178.491% |
| Flora Growth Corp. | 8.5 Million USD | 217.713% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 4037.457% |
| Evolus, Inc. | 10.99 Million USD | 191.062% |
| HUTCHMED (China) Limited | 50.25 Million USD | 119.927% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 109.463% |
| Akanda Corp. | 1.28 Million USD | 878.23% |